UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dynamics and persistence of CYP2D6 inhibition by paroxetine

Journal of clinical pharmacy and therapeutics, 2013-08, Vol.38 (4), p.294-300

2013

Volltextzugriff (PDF)

Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice

Journal of clinical pharmacy and therapeutics, 2012-08, Vol.37 (4), p.486-490

2012

Volltextzugriff (PDF)

P.2.c.008 Fading of the inhibition of CYP2D6 after paroxetine treatment discontinuation

European neuropsychopharmacology, 2008, Vol.18, p.S328-S329

2008

Volltextzugriff (PDF)

P.2.g.005 Occurrence of sexual dysfunction during the maintenance treatment with newer antidepressants (naturalistic study)

European neuropsychopharmacology, 2008, Vol.18, p.S375-S376

2008

Volltextzugriff (PDF)

Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects

General physiology and biophysics, 2003-03, Vol.22 (1), p.103

2003

Volltextzugriff (PDF)

Alternative Reliable Method for Cytochrome P450 2D6 Poor Metabolizers Genotyping

Molecular biotechnology, 2013, Vol.53 (1), p.29-40

2013

Volltextzugriff (PDF)

Use of Lithium and Depot Neuroleptics in the Treatment of Paraphilias

Journal of sex & marital therapy, 2000-10, Vol.26 (4), p.359-360

Žourková, Alexandra

2000

Volltextzugriff (PDF)

Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice: Phenotyping CYP2D6 using 3-h serum dextromethorphan MR

Journal of clinical pharmacy and therapeutics, 2012-08, Vol.37 (4), p.486-490

2012

Volltextzugriff (PDF)

P02-451 - Comparison of risperidone response rate between different CYP2D6 metabolisers

European psychiatry, 2011, Vol.26, p.1047-1047

2011

Volltextzugriff (PDF)

Relation between sexual dysfunctions and CYP 2D6 activity

European psychiatry, 2002-05, Vol.17, p.190-190

2002

Volltextzugriff (PDF)

P.2.031 A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders

European neuropsychopharmacology, 2003-10, Vol.13, p.S292-S292

2003

Volltextzugriff (PDF)

P.2.030 Olanzapine versus risperidone in first-episode schizophrenic and schizoform disorders: A double-blind comparison

European neuropsychopharmacology, 2003-10, Vol.13, p.S291-S291

2003

Volltextzugriff (PDF)

Relationship Between CYP 2D6 Metabolic Status and Sexual Dysfunction in Paroxetine Treatment

Journal of sex & marital therapy, 2002-10, Vol.28 (5), p.451-461

2002

Volltextzugriff (PDF)

Mental bulimia and paroxetine treatment - monitoring CYP2D6 activity (preliminary results)

European psychiatry, 2007-03, Vol.22, p.S179-S179

2007

Volltextzugriff (PDF)

Dexamethasone suppression test in first-episode schizophrenia

Neuro-endocrinology letters, 2006-08, Vol.27 (4), p.433-437

2006

Volltextzugriff (PDF)

P.1.147 Phenotype dynamics and its clinical correlates in patients treated by paroxetine

European neuropsychopharmacology, 2003-10, Vol.13, p.S237-S237

2003

Volltextzugriff (PDF)

P.1.146 Sertraline versus amitriptyline in the treatment of in-patients with acute depressive disorders

European neuropsychopharmacology, 2003-10, Vol.13, p.S236-S236

2003

Volltextzugriff (PDF)

P01.164 Depression and brain perfusion: A spect study

European psychiatry, 2000-10, Vol.15 (S2), p.s364-s364

2000

Volltextzugriff (PDF)

Comparison of risperidone response rate between different CYP2D6 metabolisers

European psychiatry, 2011-03, Vol.26 (S2), p.1047-1047

2011

Volltextzugriff (PDF)

Molecular genetic identification of the major CYP2D6 alleles and utilization in psychiatric treatment of depression

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.107

2008

Volltextzugriff (PDF)

Depression and sexual health

Psychiatrie pro praxi, 2022-10, Vol.23 (3), p.192-194

Žourková, Alexandra

2022

Volltextzugriff (PDF)

Barriers to the Implementation of Smart Projects in Rural Areas, Small Towns, and the City in Brno Metropolitan Area

European countryside, 2022-12, Vol.14 (4), p.675-695

2022

Volltextzugriff (PDF)

MDR1 in Paroxetine-Induced Sexual Dysfunction

Journal of sex & marital therapy, 2013-01, Vol.39 (1), p.71-78

2013

Volltextzugriff (PDF)

Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone

Neuro-endocrinology letters, 2012, Vol.33 (2), p.236-244

2012

Volltextzugriff (PDF)

Links among Paroxetine-Induced Sexual Dysfunctions, Gender, and CYP2D6 Activity

Journal of sex & marital therapy, 2007-07, Vol.33 (4), p.343-355

2007

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Adult
(8)
Female
(7)
Life Sciences & Biomedicine
(7)
Male
(7)
Middle Aged
(7)
Science & Technology
(7)
Cytochrome P-450 Cyp2d6 - Genetics
(6)
Biological And Medical Sciences
(5)
Cytochrome P-450 Cyp2d6 - Metabolism
(5)
Medical Sciences
(5)
Psychiatry
(5)
Social Sciences
(5)
Antidepressive Agents, Second-Generation - Administration & Dosage
(4)
Cyp2d6
(4)
Family Studies
(4)
Internal Medicine
(4)
Pharmacology. Drug Treatments
(4)
Psychology
(4)
Psychology, Clinical
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dynamics and persistence of CYP2D6 inhibition by paroxetine

Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice

P.2.c.008 Fading of the inhibition of CYP2D6 after paroxetine treatment discontinuation

P.2.g.005 Occurrence of sexual dysfunction during the maintenance treatment with newer antidepressants (naturalistic study)

Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects

Alternative Reliable Method for Cytochrome P450 2D6 Poor Metabolizers Genotyping

Use of Lithium and Depot Neuroleptics in the Treatment of Paraphilias

Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice: Phenotyping CYP2D6 using 3-h serum dextromethorphan MR

P02-451 - Comparison of risperidone response rate between different CYP2D6 metabolisers

Relation between sexual dysfunctions and CYP 2D6 activity

P.2.031 A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders

P.2.030 Olanzapine versus risperidone in first-episode schizophrenic and schizoform disorders: A double-blind comparison

Relationship Between CYP 2D6 Metabolic Status and Sexual Dysfunction in Paroxetine Treatment

Mental bulimia and paroxetine treatment - monitoring CYP2D6 activity (preliminary results)

Dexamethasone suppression test in first-episode schizophrenia

P.1.147 Phenotype dynamics and its clinical correlates in patients treated by paroxetine

P.1.146 Sertraline versus amitriptyline in the treatment of in-patients with acute depressive disorders

P01.164 Depression and brain perfusion: A spect study

Comparison of risperidone response rate between different CYP2D6 metabolisers

Molecular genetic identification of the major CYP2D6 alleles and utilization in psychiatric treatment of depression

Depression and sexual health

Barriers to the Implementation of Smart Projects in Rural Areas, Small Towns, and the City in Brno Metropolitan Area

MDR1 in Paroxetine-Induced Sexual Dysfunction

Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone

Links among Paroxetine-Induced Sexual Dysfunctions, Gender, and CYP2D6 Activity

Suchergebnisse filtern